Baird Medical Expands into San Francisco, Advancing U.S. Market Growth | PR Newswire [Video]

, /PRNewswire/ — Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a leader in minimally invasive Microwave Ablation (MWA) technology, is expanding its presence into San Francisco, marking an important step in its U.S. growth strategy. This expansion follows the recent J.P. Morgan Health Conference in San Francisco, highlighting the company’s early success in executing its strategic vision for medical innovation.

As part of this development, Dr. Terrence K. Trapp, an experienced otolaryngologist, has integrated the Company’s MWA system into his practice, suggesting growing interest and recognition of minimally invasive approaches for managing thyroid nodules.

Since receiving FDA 510(k) clearance in November 2023, Baird Medical has treated hundreds of patients in the United States with its MWA technology, all of whom have experienced significant recovery and positive treatment outcomes. This growing adoption is exemplified by physicians like Dr. Emad Kandil, Professor of Surgery and Ellis Hanna Chair at Tulane University, …